Denali Therapeutics, Inc. (DNLI)
17.57
-2.09
(-10.63%)
USD |
NASDAQ |
Dec 10, 16:00
17.54
-0.02
(-0.14%)
After-Hours: 20:00
Denali Therapeutics Free Cash Flow: -410.85M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Masimo Corp. | 188.70M |
| Novavax, Inc. | -384.71M |
| iRhythm Technologies, Inc. | 32.42M |
| AIM ImmunoTech, Inc. | -13.33M |
| Protalix Biotherapeutics, Inc. | -11.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -107.30M |
| Cash from Investing (Quarterly) | 57.83M |
| Cash from Financing (Quarterly) | -0.778M |
| Free Cash Flow Per Share (Quarterly) | -0.6143 |
| Free Cash Flow to Equity (Quarterly) | -103.76M |
| Free Cash Flow to Firm (Quarterly) | -105.92M |
| Free Cash Flow Yield | -13.65% |